|
Defective
Medical Products
The Federal Food and Drug administration is the agency in
charge of monitoring medical devices in this country. According
to the Federal Food, Drug and Cosmetic Act, there are at least
1800 categories of medical devices. Some of the more common
devices include heart valves, pacemakers, prosthetic knee
and hip devices, ventilators, x-ray machines, biopsy equipment,
ultrasound, and infusion pumps.
Before medical devices become available for use, the manufacturer
must first obtain approval for marketing that product from
the FDA. Since 1976, the FDA has required that new medical
devices be proven safe and effective before being marketed.
However, in spite of a rigorous premarket process, medical
devices are only as safe as the information known at the moment
in time when the review process takes place.
Typically, the clinical trials upon which premarket approval
is based, may only involve a few hundred patients. More importantly,
most medical devices are not tested functionally, or in real
life situations. Most testing is performed as "bench
testing" (based on the concept of putting the device
on a bench and hitting it in different ways). Thus, even if
the FDA grants premarket approval to a device manufacturer,
healthcare professionals and the public at large cannot assume
that the FDA has determined that the product is absolutely
safe for human use.
Moreover, just because the FDA approves a device for a particular
use, this does not preclude a physician from prescribing that
device for non-approved uses. This is because the physicians
are not governed by the FDA approved uses. Only the manufacturer
is governed by the FDA in terms of how it can market the product
for use.
An example of this arose recently in a prosthetic knee device
approved by the FDA for use with bone cement. However, the
device was designed with the idea that bone cement would not
be necessary because the bone could grow through porous holes
in the device(bony in growth). Since the FDA only approved
the device for cemented use, the manufacturer was prohibited
from marketing the device for bony in growth. However, the
physicians knew of the bony in growth potential and were actively
implanting the device without bone cement. When the device
ultimately failed, the physicians were upset with the manufacturer
for not informing them of this limitation in advance.
The FDA requires "device user facilities" and manufacturers
and distributors to promptly notify the FDA about device-related
failures or events that may have caused a death, serious injury,
or illness. These reports called Medical Device Reports (MDR's),
are required to ensure that the most serious problems will
be identified to the user. Typically, problems with medical
devices fall into one of three broad categories: (i) Device
problems; (ii) Use problems; and (iii) Clinical problems.
Each year, the FDA receives approximately 100,000 reports
through the MDR route and another 5,000 device reports through
the voluntary MedWatch route. Nurses submit about 25% of the
voluntary reports with biomedical engineers submitting 21%
of these reports. Physicians only submit about 8% of these
reports.
The Cochran Firm - Dallas, L.L.P.
Turtle Creek Centre, Suite 1400
3811 Turtle Creek Boulevard
Dallas, Texas
75219
phone:
214.651.4260
| fax: 214.651.4261
Edward H. Moore is Board Certified, Personal Injury Trial Law. Unless otherwise noted, not certified by the Texas Board of Legal Specialization.
The statements and information provided on this web site are for the information of the recipient only. This site is not intended to provide legal advice and no attorney-client relationship should be deemed to arise from the receipt this page and its associated pages. |
Copyright © 2003 The Cochran Firm - Dallas, L.L.P.,
All Rights Reserved.
|
|